The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
463 - Is DTC advertising (i.e. patient support website, journal ads, and waiting room brochures) allowed for a schedule D biologic that is not used to treat or cure a schedule A disease?
DTCA/I, consumer secondary audience
1
Posts
1
Posters
384
Views
1
Watching
-
Yes. Take vaccines for example. Use the following to guide creation of the advertisement: http://www.hc-sc.gc.ca/dhp-mps/advert-publicit/pol/guide-ldir_consom_consum-eng.php http://www.hc-sc.gc.ca/dhp-mps/advert-publicit/pol/guide-ldir_dtca-pdac_vaccine-vaccins-eng.php Note that Health Canada is updating the consumer advertising guidelines to include provisions explicitly for vaccines. Please ensure that the product is not dual scheduled (i.e. both schedule D + schedule prescription). Otherwise the prescription product restrictions (name/price/qty) set the advertising restrictions.
